Adriamycin-resistant MCF-7 cells could pack the up-regulated TRPC5 channels into mobile extracellular vesicles (EVs), which are released in tumor microenvironment and transferred their signaling content to surrounding endothelial cells. This evidence concerns the gene TRPC5 and neoplasm.